Table 5. Changes in free amino acid content of farro according to liquefaction conditions (μg/mL)
Sample1) | PET | LTC (min) | F-value5) |
30 | 60 | 90 |
Threonine | 3.50±0.022)a3) | 0.73±0.03b | 0.70±0.01c | 0.66±0.01c | 16,403.124*** |
Cysteine | 0.42±0.00 | ND4) | ND | ND | - |
Tyrosine | 2.15±0.02a | 0.68±0.02b | NDd | 0.24±0.01c | 15,892.381*** |
Arginine | 11.16±0.05a | 3.07±0.05b | 0.19±0.03c | 0.13±0.01c | 64,448.642*** |
Alanine | 5.98±0.02a | 2.22±0.02b | 1.37±0.01d | 1.75±0.02c | 42,977.506*** |
Proline | 13.60±0.48a | 1.95±0.14b | 2.30±0.20b | 2.19±0.10b | 1,312.891*** |
Lysine | 2.09±0.02a | 0.22±0.02b | NDc | NDc | - |
Histidine | 1.76±0.02a | 0.68±0.09b | 0.69±0.01b | 0.58±0.02c | 446.597*** |
Isoleucine | 2.94±0.02 | ND | ND | ND | - |
Leucine | 7.08±0.03a | 0.17±0.02b | NDc | NDc | - |
Methionine | 1.80±0.01 | ND | ND | ND | - |
Phenylalanine | 7.41±0.05a | 0.43±0.02b | NDc | NDc | - |
Tryptophan | 4.23±0.03a | 3.56±0.10b | 3.56±0.02b | 3.51±0.06b | 102.992*** |
Valine | 4.62±0.02a | 0.47±0.03b | 0.28±0.01c | 0.30±0.01c | 42,162.462*** |
Glutamic acid | 9.15±0.06a | 2.12±0.06c | 1.90±0.01d | 2.41±0.06b | 14,161.383*** |
Aspartic acid | 7.90±0.22a | 6.18±0.15c | 7.78±0.14a | 7.43±0.08b | 73.960*** |
Serine | 6.75±0.05a | 0.78±0.02b | 0.80±0.01b | 0.63±0.01c | 37,865.984*** |
Glycine | 3.93±0.03a | 1.51±0.037b | 1.31±0.01d | 1.39±0.01c | 11,518.027*** |
Total AA | 96.45±0.65a | 24.78±0.47b | 20.88±0.32c | 21.22±0.15c | 21,582.543*** |
PET, pre-enzyme treatment; LTC, liquefaction treatment conditions; 30, liquefaction for 30 min; 60, liquefaction for 60 min; 90, liquefaction for 90 min.
All values are mean±SD (n=3).
Different superscript letters (a-c) in the same row indicate significant differences (p<0.05) by Duncan’s multiple range test.
ND, not detected.
The significance of each coefficient was detrmined using both the F-value (Fisher test value) and p-value(*Significant at p<0.1; **Significant at p<0.05; ***Significant at p<0.01).